Fiera Capital Corp Invests $24.21 Million in Agilent Technologies, Inc. $A

Fiera Capital Corp acquired a new position in shares of Agilent Technologies, Inc. (NYSE:A) in the 4th quarter, HoldingsChannel reports. The institutional investor acquired 177,934 shares of the medical research company’s stock, valued at approximately $24,211,000.

Several other large investors have also modified their holdings of the stock. Massachusetts Financial Services Co. MA boosted its stake in shares of Agilent Technologies by 13.8% during the 4th quarter. Massachusetts Financial Services Co. MA now owns 14,147,601 shares of the medical research company’s stock worth $1,925,064,000 after acquiring an additional 1,713,216 shares in the last quarter. Wellington Management Group LLP boosted its stake in shares of Agilent Technologies by 4.8% during the 3rd quarter. Wellington Management Group LLP now owns 9,380,521 shares of the medical research company’s stock worth $1,203,990,000 after acquiring an additional 433,342 shares in the last quarter. Geode Capital Management LLC boosted its stake in shares of Agilent Technologies by 0.3% during the 4th quarter. Geode Capital Management LLC now owns 7,425,861 shares of the medical research company’s stock worth $1,006,519,000 after acquiring an additional 25,139 shares in the last quarter. Generation Investment Management LLP boosted its stake in shares of Agilent Technologies by 10.1% during the 3rd quarter. Generation Investment Management LLP now owns 6,357,953 shares of the medical research company’s stock worth $816,043,000 after acquiring an additional 582,093 shares in the last quarter. Finally, Norges Bank bought a new stake in shares of Agilent Technologies during the 4th quarter worth $549,158,000.

Agilent Technologies Trading Down 1.9%

Agilent Technologies stock opened at $132.88 on Tuesday. The company has a debt-to-equity ratio of 0.43, a current ratio of 2.10 and a quick ratio of 1.62. The company has a market capitalization of $37.53 billion, a price-to-earnings ratio of 26.68, a PEG ratio of 2.41 and a beta of 1.26. Agilent Technologies, Inc. has a one year low of $108.35 and a one year high of $160.27. The company’s fifty day moving average price is $118.73 and its two-hundred day moving average price is $128.16.

Agilent Technologies (NYSE:A) last posted its earnings results on Wednesday, May 27th. The medical research company reported $1.49 EPS for the quarter, topping the consensus estimate of $1.41 by $0.08. The firm had revenue of $1.84 billion for the quarter, compared to the consensus estimate of $1.80 billion. Agilent Technologies had a net margin of 19.55% and a return on equity of 24.33%. The business’s quarterly revenue was up 10.0% on a year-over-year basis. During the same period in the prior year, the business posted $1.31 earnings per share. Agilent Technologies has set its FY 2026 guidance at 6.000-6.100 EPS and its Q3 2026 guidance at 1.480-1.500 EPS. On average, analysts forecast that Agilent Technologies, Inc. will post 5.99 earnings per share for the current fiscal year.

Agilent Technologies Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Wednesday, July 22nd. Shareholders of record on Tuesday, June 30th will be given a dividend of $0.255 per share. This represents a $1.02 annualized dividend and a yield of 0.8%. The ex-dividend date of this dividend is Tuesday, June 30th. Agilent Technologies’s dividend payout ratio is presently 20.48%.

Analyst Ratings Changes

Several research firms have recently weighed in on A. Weiss Ratings raised Agilent Technologies from a “hold (c-)” rating to a “hold (c)” rating in a research note on Tuesday, June 2nd. UBS Group decreased their target price on Agilent Technologies from $180.00 to $165.00 and set a “buy” rating for the company in a research report on Thursday, February 26th. Royal Bank Of Canada began coverage on Agilent Technologies in a research report on Wednesday, May 27th. They issued an “outperform” rating and a $153.00 target price for the company. Wells Fargo & Company decreased their target price on Agilent Technologies from $165.00 to $160.00 and set an “overweight” rating for the company in a research report on Thursday, May 28th. Finally, Morgan Stanley decreased their target price on Agilent Technologies from $180.00 to $160.00 and set an “overweight” rating for the company in a research report on Tuesday, March 3rd. One research analyst has rated the stock with a Strong Buy rating, thirteen have issued a Buy rating and two have issued a Hold rating to the company’s stock. According to data from MarketBeat, Agilent Technologies currently has an average rating of “Moderate Buy” and an average price target of $161.71.

Agilent Technologies Profile

Agilent Technologies is a global provider of scientific instrumentation, consumables, software and services for laboratories across the life sciences, diagnostics and applied chemical markets. The company’s product portfolio includes analytical instruments such as liquid and gas chromatographs, mass spectrometers, spectroscopy systems, and laboratory automation solutions, together with reagents, supplies and informatics tools that support measurement, testing and data analysis workflows. Agilent also offers instrument maintenance, qualification and laboratory services designed to help customers improve productivity and comply with regulatory requirements.

Founded as a corporate spin-off from Hewlett?Packard in 1999, Agilent has evolved through a combination of strategic restructuring and acquisitions to concentrate on life sciences, diagnostics and applied laboratories.